Table 2.
Underlying nephropathy and medication list of all 31 CKD patients pre– and 3 to 6 months post–renal transplantation
| CKD | 3 months after transplantation | 6 months after transplantation | |
|---|---|---|---|
| Primary/underlying renal disease | |||
| Hypertensive nephropathy | 4 | — | — |
| Diabetic nephropathy | 1 | — | — |
| ADPKD | 8 | — | — |
| Primary FSGS | 4 | — | — |
| IgA nephritis | 7 | — | — |
| Reflux nephropathy | 4 | — | — |
| Mesangioproliferative GN | 1 | — | — |
| Unknown | 2 | — | — |
| Medication | |||
| Immunosuppression | 1 | 29 | 31 |
| Tacrolimus | 0 | 25 | 27 |
| Cyclosporine | 0 | 3 | 1 |
| Mycophenolate mofetil | 0 | 29 | 30 |
| Belatacept | 0 | 1 | 1 |
| Sirolimus | 0 | 0 | 2 |
| Azathioprine | 0 | 0 | 1 |
| Prednisolone | 1 | 29 | 31 |
| Daily dosage | 1 mg/d | 7.5 mg/d (IQR 2.5) | 5 mg/d (IQR 0) |
| Antihypertensive medication | 31 | 28 | 26 |
| ARB | 13 | 16 | 10 |
| ACEi | 6 | 7 | 8 |
| Diuretics | 14 | 2 | 3 |
| Calcium antagonist | 19 | 16 | 10 |
| ß-Blocker | 14 | 17 | 13 |
| Aldosterone antagonist | 0 | 0 | 1 |
| Others | 15 | 9 | 7 |
| Bicarbonate | 24 | 4 | 0 |
| Statins | 15 | 29 | 27 |
| Phosphate binder | 17 | 0 | 0 |
| Antidiabetic medication (insulin, glinides, gliptins) | 2 | 6 | 3 |
ADPKD, autosomal dominant polycystic kidney disease; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CKD, chronic kidney disease; FSGS, focal segmental glomerulosclerosis; GN, glomerulonephritis; IgA, immunoglobulin A; IQR, interquartile range.